Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Korea To Limit Olmutinib Usage, Monitor All Patients

Oct 05 2016

• By Jung Won Shin

SC1609_SouthKoreaMap_1200x675

Related Content

Korean Authorities Mull New Steps, Probe Over Olmutinib Events

Oct 03 2016

Surprise Boehringer Decision Turns Hanmi Investors’ Hopes To Despair

Sep 30 2016

Related Companies

Hanmi Pharmaceutical Co., Ltd.

Boehringer Ingelheim GmbH

Additional Topics

South Korea Asia Pacific Safety Regulation BioPharmaceutical

More from Drug Safety

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window